PMC:7253233 / 6870-6960 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"249","span":{"begin":36,"end":46},"obj":"Chemical"},{"id":"250","span":{"begin":48,"end":57},"obj":"Chemical"},{"id":"251","span":{"begin":63,"end":72},"obj":"Chemical"}],"attributes":[{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"MESH:D014640"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"MESH:D000077731"},{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"MESH:D000212"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Antibiotic regimen was broadened to Vancomycin, Meropenem, and Acyclovir for CSF coverage."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T31","span":{"begin":77,"end":80},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma20935"}],"text":"Antibiotic regimen was broadened to Vancomycin, Meropenem, and Acyclovir for CSF coverage."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":36,"end":46},"obj":"Chemical"},{"id":"T14","span":{"begin":48,"end":57},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_28001"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_43968"}],"text":"Antibiotic regimen was broadened to Vancomycin, Meropenem, and Acyclovir for CSF coverage."}

{"project":"LitCovid-sentences","denotations":[{"id":"T55","span":{"begin":0,"end":90},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Antibiotic regimen was broadened to Vancomycin, Meropenem, and Acyclovir for CSF coverage."}